← Leaderboards
Brigitte T. Huber
Tufts University Boston
$10,217,193
Attributed
$10,217,193
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$10,217,193 · 16
By mechanism
R01$7,694,419 · 4
R37$1,776,830 · 1
T32$601,035 · 1
P41$144,909 · 10
Top collaborators
No co-investigators on record.
Most similar at Tufts University Boston
Same institution · by research overlap
- Melisa S Medrano$137,278
- Meghan E Ramsey$109,770
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseProteinsGrantResearch PersonnelAffectPolymerase Chain ReactionGenetically Modified AnimalsAutoantigensProductionT-LymphocyteAntigensMhc Class Ii AntigenBaseInfectionImmune SystemSuperantigensHuman SubjectAntibodiesHervsInflammationPatternGene ExpressionAllelesCharacteristics
Grant awards (43)
HERV-K18 as a Risk Factor for CFIDS$295,269
R01 · FY2011 · AR · contact PI
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS$12,768
P41 · FY2011 · RR · contact PI
HERV-K18 as a Risk Factor for CFIDS$307,572
R01 · FY2010 · AR · contact PI
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS$2,425
P41 · FY2010 · RR · contact PI
HERV-K18 as a Risk Factor for CFIDS$310,679
R01 · FY2009 · AR · contact PI
B Lymphocytes Differentiation and Triggering$468,895
R01 · FY2008 · AI · contact PI
HERV-K18 as a Risk Factor for CFIDS$310,315
R01 · FY2008 · AR · contact PI
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS$5,187
P41 · FY2008 · RR · contact PI
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS$5,187
P41 · FY2008 · RR · contact PI
B Lymphocytes Differentiation and Triggering$464,055
R01 · FY2007 · AI · contact PI
HERV-K18 as a Risk Factor for CFIDS$332,184
R01 · FY2007 · AR · contact PI
QPP: Protease that Prevents Apoptosis in Quiescent Cells$300,573
R01 · FY2007 · AI · contact PI
Multidisciplinary Biodefense Training Program$117,612
T32 · FY2007 · AI · contact PI
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS$8,619
P41 · FY2007 · RR · contact PI
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS$8,619
P41 · FY2007 · RR · contact PI
B Lymphocytes Differentiation and Triggering$463,996
R01 · FY2006 · AI · contact PI
QPP: Protease that Prevents Apoptosis in Quiescent Cells$309,551
R01 · FY2006 · AI · contact PI
Multidisciplinary Biodefense Training Program$121,574
T32 · FY2006 · AI · contact PI
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETR$27,332
P41 · FY2006 · RR · contact PI
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS$11,330
P41 · FY2006 · RR · contact PI
B Lymphocytes Differentiation and Triggering$461,322
R01 · FY2005 · AI
Chronic Lyme Arthritis: Is this Autoimmunity?$317,000
R01 · FY2005 · AR
QPP: Protease that Prevents Apoptosis in Quiescent Cells$317,000
R01 · FY2005 · AI
Multidisciplinary Biodefense Training Program$121,574
T32 · FY2005 · AI
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETR$27,261
P41 · FY2005 · RR
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS$11,301
P41 · FY2005 · RR
B Lymphocytes Differentiation and Triggering$458,318
R01 · FY2004 · AI
QPP: Protease that Prevents Apoptosis in Quiescent Cells$317,000
R01 · FY2004 · AI
Chronic Lyme Arthritis: Is this Autoimmunity?$317,000
R01 · FY2004 · AR
Multidisciplinary Biodefense Training Program$121,484
T32 · FY2004 · AI
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETRY$24,880
P41 · FY2004 · RR
B LYMPHOCYTES--DIFFERENTIATION AND TRIGGERING$464,424
R37 · FY2003 · AI
Chronic Lyme Arthritis: Is this Autoimmunity?$317,000
R01 · FY2003 · AR
QPP: Protease that Prevents Apoptosis in Quiescent Cells$180,803
R01 · FY2003 · AI
Multidisciplinary Biodefense Training Program$118,791
T32 · FY2003 · AI
B LYMPHOCYTES--DIFFERENTIATION AND TRIGGERING$450,898
R37 · FY2002 · AI
Chronic Lyme Arthritis: Is this Autoimmunity?$317,000
R01 · FY2002 · AR
B LYMPHOCYTES--DIFFERENTIATION AND TRIGGERING$437,765
R37 · FY2001 · AI
Chronic Lyme Arthritis: Is this Autoimmunity?$317,000
R01 · FY2001 · AR
PROTEASE THAT PREVENTS APOPTOSIS IN QUIESCENT CELLS$293,098
R01 · FY2001 · AI
B LYMPHOCYTES--DIFFERENTIATION AND TRIGGERING$423,743
R37 · FY2000 · AI
PROTEASE THAT PREVENTS APOPTOSIS IN QUIESCENT CELLS$282,857
R01 · FY2000 · AI
CHRONIC LYME ARTHRITIS--IS THIS AUTOIMMUNITY?$235,932
R01 · FY2000 · AR